[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100631629":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":10,"centralContacts":20,"locations":30,"responsibleParty":46,"collaborators":10,"id":48,"slug":49,"hasResults":50,"nctId":51,"briefTitle":52,"officialTitle":52,"acronym":10,"eligibilityCriteria":53,"healthyVolunteers":54,"sex":55,"minAge":56,"maxAge":57,"enrollmentInfo":58,"targetDuration":61,"studyType":62,"phases":10,"briefSummary":63,"conditions":64,"keywords":67,"overallStatus":70,"whyStopped":10,"lastUpdateSubmitDate":71,"lastUpdatePostDateStruct":72,"startDateStruct":75,"completionDateStruct":77,"leadSponsor":79,"locationsCount":80},{"fullName":5,"class":6},"Nihon Kohden","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Adult healthy subjects",null,"Adult healthy subjects capable of undergoing controlled hypoxemia and hemodilution procedures.",[13],"Device: Noninvasive Physiological Monitoring Device",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":10},"DEVICE","Noninvasive Physiological Monitoring Device","Octopal R Noninvasive Pulse Wave Measuring Device DMO-8000X with TL 811S Finger Probe",[9],[21,26],{"name":22,"role":23,"phone":24,"phoneExt":10,"email":25},"Greg Stratmann, MD, PhD","CONTACT","(650) 868-5155","stratman@anesthesia.ucsf.edu",{"name":27,"role":23,"phone":28,"phoneExt":10,"email":29},"Steve Weisner, MS","617-318-5904","steve_weisner@nihonkohden.com",[31],{"facility":32,"status":10,"city":33,"state":34,"zip":35,"country":36,"countryCode":37,"cosmosGeoPoint":38,"geoPoint":43,"contacts":44},"Vital Sign Research Group","San Francisco","California","94107","United States","US",{"type":39,"coordinates":40},"Point",[41,42],-122.41942,37.77493,{"lat":42,"lon":41},[45],{"name":22,"role":23,"phone":24,"phoneExt":10,"email":25},{"type":47,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100631629","hypoxia-and-hemodilution-testing-in-healthy-adult-volunteers-100631629",false,"NCT07503171","Hypoxia and Hemodilution Testing in Healthy Adult Volunteers","Inclusion Criteria:\n\n1. In good general health with no evidence of significant medical problems.\n2. Fluent in both written and spoken English.\n\n4\\. Has provided written informed consent and is willing to comply with study procedures.\n\nExclusion Criteria:\n\n1. BMI above 30.\n2. History of heart, lung, kidney, or liver disease.\n3. Diagnosis of asthma, sleep apnea, or use of CPAP.\n4. Diabetes mellitus.\n5. Clotting disorders.\n6. Hemoglobinopathy or history of anemia (ctHb \\\u003C12 g\u002FdL for men, \\\u003C11 g\u002FdL for women, COHb \\>2%).\n7. Any serious systemic illness.\n8. Current smoker.\n9. Injury or abnormality at sensor sites interfering with measurements.\n10. History of fainting or vasovagal response.\n11. Sensitivity to local anesthesia.\n12. Diagnosis of Raynaud's disease.\n13. Unacceptable collateral circulation (Allen's test).\n14. Pregnant, lactating, or attempting to become pregnant.\n15. Unable or unwilling to provide informed consent or comply with study procedures.\n16. Any other condition deemed unsuitable by the investigator.",true,"ALL","18 Years","35 Years",{"count":59,"type":60},7,"ESTIMATED","1 Week","OBSERVATIONAL","This study will collect physiological measurements in healthy adult volunteers under controlled hypoxia and hemodilution conditions.",[65,66],"Hypoxia","Hemodilution",[68,69],"Pulse oximetry","Hb","NOT_YET_RECRUITING","2026-03-25",{"date":73,"type":74},"2026-03-31","ACTUAL",{"date":76,"type":60},"2026-04-02",{"date":78,"type":60},"2028-01-31",{"name":5,"class":6},1]